EUVIMED · CrossrefZeitschrift
Oncology Reviews
ISSN 1970-5565 · Frontiers Media SA
Neueste Artikel
Management of Neuroendocrine Breast Carcinoma (NEBC): Review of Literature
Palliative Care for Cancer Patients in Asia: Challenges and Countermeasures
Glucose transporters as markers of diagnosis and prognosis in cancer diseases
Published randomized controlled trials of surveillance in cancer patients - a systematic review
Metformin - its anti-cancer effects in hematologic malignancies
Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy
Epithelial-mesenchymal interconversions in ovarian cancer: The levels and functions of E-cadherin in intraabdominal dissemination
Management of cytotoxic chemotherapy-induced hand-foot syndrome
EPAC2: A new and promising protein for glioma pathogenesis and therapy
Mitotic quiescence in hepatic cancer stem cells: An incognito mode
Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions
Potential effect of probiotics in the treatment of breast cancer
Thrombocytopenia in solid tumors: Prognostic significance
Advances in pancreatic cancer biomarkers
Post-transcriptional regulation of microRNAs in cancer: From prediction to validation
Bone metastases: an overview
Progress in treatment of viral infections in children with acute lymphoblastic leukemia
Red meat and colorectal cancer
Oral field cancerization: an update on current concepts
The role of microRNAs in stemness of cancer stem cells
Systemic adjuvant therapies in renal cell carcinoma
Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
Thrombosis and bleeding in cancer patients
Testicular tumors
Low molecular weight heparins in cancer patients: to treat thromboembolic events, the tumor, or both?
Improving clinical trial design for hepatocellular carcinoma treatments
Advances in diffuse malignant peritoneal mesothelioma
ASCO 2007: “Translating Research into Practice”. Report from the 34th annual meeting of the American Society of Clinical Oncology
Temisorlimus in the treatment of advanced renal cell carcinoma
Oncology reviews: reasons for a new oncology journal
EUVIMED